FBN1 and Marfan syndrome: Knowledge of the effects of genetic variants elsewhere outside of FBN1 on the frequency and progression of the cardiovascular phenotype in patients with MFS is very limited; therefore, deepening our understanding of this phenomenon is very important to improve the clinical management/risk stratification of patients.